These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13379340)

  • 21. [BCG immunization of school children in Courbevoie; preliminary results].
    NICO JF; LOUSTEAU-CHARTEZ M
    Rev Tuberc; 1951; 15(12):1078-82. PubMed ID: 14921528
    [No Abstract]   [Full Text] [Related]  

  • 22. BCG vaccination in children.
    von Reyn CF; Zumla AI
    BMJ; 2008 Nov; 337():a2086. PubMed ID: 19008270
    [No Abstract]   [Full Text] [Related]  

  • 23. A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice.
    Tanghe A; Adnet PY; Gartner T; Huygen K
    Infect Immun; 2007 May; 75(5):2642-4. PubMed ID: 17325046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCG.
    Vordermeier HM; Huygen K; Singh M; Hewinson RG; Xing Z
    Infect Immun; 2006 Feb; 74(2):1416-8. PubMed ID: 16428796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of so-called cutaneous tuberculosis by BCG vaccination].
    GEHRELS PE
    Z Haut Geschlechtskr; 1956 Apr; 20(8):228-37. PubMed ID: 13325681
    [No Abstract]   [Full Text] [Related]  

  • 26. First data on Eurasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain.
    Ballesteros C; Garrido JM; Vicente J; Romero B; Galindo RC; Minguijón E; Villar M; Martín-Hernando MP; Sevilla I; Juste R; Aranaz A; de la Fuente J; Gortázar C
    Vaccine; 2009 Nov; 27(48):6662-8. PubMed ID: 19747578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Duration of postvaccinal allergy in BCG vaccination and revaccination in Algeria].
    FOLEY H; PARROT L
    Arch Inst Pasteur Alger; 1954 Mar; 32(1):9-14. PubMed ID: 13181527
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunization with Single Oral Dose of Alginate-Encapsulated BCG Elicits Effective and Long-Lasting Mucosal Immune Responses.
    Hosseini M; Dobakhti F; Pakzad SR; Ajdary S
    Scand J Immunol; 2015 Dec; 82(6):489-97. PubMed ID: 26286252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV].
    Nikonenko BV; Mezhlumova MB; Moroz AM
    Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge.
    Cai H; Yu DH; Hu XD; Li SX; Zhu YX
    DNA Cell Biol; 2006 Aug; 25(8):438-47. PubMed ID: 16907641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of circulating antibodies after BCG immunization as assayed by the globulin titration technique.
    FUSILLO MH; WEISS DL
    Am Rev Tuberc; 1958 Nov; 78(5):793. PubMed ID: 13583446
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antituberculous vaccination with freeze dried BCG vaccine. I. Properties of the dry BCG vaccine].
    KURYLOWICZ W
    Gruzlica (1926); 1955 Jan; 23(1):1-11. PubMed ID: 13251577
    [No Abstract]   [Full Text] [Related]  

  • 33. A study of the cutaneous absorption of BCG vaccine labelled with radioactive phosphate in subjects with or without immunity.
    STROM L
    Acta Tuberc Scand; 1955; 31(2):141-62. PubMed ID: 13326596
    [No Abstract]   [Full Text] [Related]  

  • 34. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.
    Heinzmann J; Wilkens M; Dohmann K; Gerlach GF
    Vet Microbiol; 2008 Aug; 130(3-4):330-7. PubMed ID: 18343053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine protocols to optimise the protective efficacy of BCG.
    Griffin JF; Mackintosh CG; Slobbe L; Thomson AJ; Buchan GS
    Tuber Lung Dis; 1999; 79(3):135-43. PubMed ID: 10656112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cutaneous administration of BCG vaccine].
    NAKHIMSON LI; PROKOFEVA AV
    Probl Tuberk; 1945; (3):43-6. PubMed ID: 20275252
    [No Abstract]   [Full Text] [Related]  

  • 38. [OBTAINING ANTI-GLOBULIN SERUM BY IMMUNIZATION OF RABBITS BY THE FREUND METHOD].
    KALUZHENKO RK
    Lab Delo; 1963 Apr; 9():41-2. PubMed ID: 14064265
    [No Abstract]   [Full Text] [Related]  

  • 39. [The project of public administration relative to the vaccination by BCG vaccine].
    COURCOUX A
    Bull Acad Natl Med; 1951 Jun 5-12; 135(19-20):312-4. PubMed ID: 14858946
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cutaneous allergy by tuberculin and the BCG test].
    STEINER PM; WIGNIOLLE R
    Schweiz Z Tuberk; 1953; 10(6):417-47. PubMed ID: 13156595
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.